SCHEMBL9045887

SCHEMBL9045887

CCOC(OCC)[C@@H]1CSCN1C(=O)[C@H]1NCC(=S)C1C(=O)CC1Cc2ccccc2C1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PREP P48147 17/20 0.38
FFAR1 O14842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9048108 0.95 PREP (0.42) PREP
SCHEMBL9048958 0.95 PREP (0.42) PREP
SCHEMBL9050988 0.92 PREP (0.40) PREPFFAR1
SCHEMBL9048101 0.91 PREP (0.47) PREP
SCHEMBL9049871 0.89 PREP (0.37) PREPFFAR1
SCHEMBL9047884 0.89 PREP (0.37) PREPFFAR1
SCHEMBL9049825 0.88 PREP (0.39) PREPFFAR1
SCHEMBL9046571 0.87 PREP (0.44) PREP
SCHEMBL9047036 0.87 PREP (0.44) PREP
SCHEMBL9048329 0.85 PREP (0.39) PREPFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed